JAK inhibition in the type I interferonopathies

Affiliations

¹ MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, United Kingdom; University of Paris, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, Paris, France. Electronic address: yanickcrow@mac.com.
² University of Paris, Paris, France; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP Centre Université de Paris, Paris, France; INSERM UMR 1163, Laboratory of Immunogenetics of Pediatric Autoimmunity, Imagine Institute, Paris, France.
³ University of Paris, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, Paris, France; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP Centre Université de Paris, Paris, France.

Editorial

Yanick J Crow et al. J Allergy Clin Immunol. 2021 Oct.

. 2021 Oct;148(4):991-993.

doi: 10.1016/j.jaci.2021.07.028. Epub 2021 Aug 8.

¹ MRC Human Genetics Unit, Institute of Genetics and Cancer, The University of Edinburgh, Edinburgh, United Kingdom; University of Paris, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, Paris, France. Electronic address: yanickcrow@mac.com.
² University of Paris, Paris, France; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP Centre Université de Paris, Paris, France; INSERM UMR 1163, Laboratory of Immunogenetics of Pediatric Autoimmunity, Imagine Institute, Paris, France.
³ University of Paris, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, Paris, France; Pediatric Hematology-Immunology and Rheumatology Department, Hôpital Necker-Enfants Malades, AP-HP Centre Université de Paris, Paris, France.

No abstract available

Keywords: JAK inhibition; Type I interferonopathies.

Publication types